JPMorgan Chase & Co. (JPM) Presents at UBS Financial Services Brokers Conference (Transcript) — Neutral
JPM Seeking Alpha — February 11, 2025JPMorgan Chase & Co. (NYSE:JPM ) UBS Financial Services Conference February 11, 2025 9:40 AM ET Company Participants Jeremy Barnum - Chief Financial Officer Conference Call Participants Erika Najarian - UBS Erika Najarian Hey guys, so welcome back, welcome back. We have the charismatic CFO of J.P.

Watts Water Technologies, Inc. (WTS) Q4 2024 Earnings Call Transcript — Neutral
WTS Seeking Alpha — February 11, 2025Watts Water Technologies, Inc. (NYSE:WTS ) Q4 2024 Earnings Conference Call February 11, 2025 9:00 AM ET Company Participants Diane McClintock - SVP, FP&A and IR Robert Pagano - President and CEO Shashank Patel - CFO Conference Call Participants Andrew Krill - Deutsche Bank AG Nathan Jones - Stifel Bryan Blair - Oppenheimer Michael Halloran - Baird David Tarantino - KeyBanc Capital Markets Zain Khan - TD Cowen Nick Cash - Goldman Sachs Operator Welcome to Watts Water Technologies Incorporated Fourth Quarter and Full Year 2024 Earnings Call. At the end of the presentation, we will open the live for …

Construction Partners (ROAD) is an Incredible Growth Stock: 3 Reasons Why — Positive
ROAD Zacks Investment Research — February 11, 2025Construction Partners (ROAD) possesses solid growth attributes, which could help it handily outperform the market.

Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report – Hagens Berman — Neutral
REGN Accesswire — February 11, 2025SAN FRANCISCO, CA / ACCESS Newswire / February 11, 2025 / Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is facing mounting pressure on multiple fronts. Following disappointing sales figures and ongoing legal challenges, analysts TD Cowen recently lowered its price target for Regeneron to $1,030 from $1,230.

Origin Agritech Limited (SEED) Q4 2024 Earnings Call Transcript — Neutral
SEED Seeking Alpha — February 11, 2025Origin Agritech Limited (NASDAQ:SEED ) Q4 2024 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Matthew Abenante - Strategic Investor Relations Weibin Yan - Chief Executive Officer Patrick Cheng - Chief Financial Officer Conference Call Participants Operator Thank you for standing by, and welcome to the Origin Agritech Fiscal Year 2024 Conference Call. Please note that, today's call is being recorded.

Yield Hunting Part 8: 7%+ In 1 Year From Crescent Capital BDC Baby Bonds — Positive
CCAP Seeking Alpha — February 11, 2025Crescent Capital BDC focuses on originating and investing in the debt of private middle-market U.S. companies, aiming for income and capital appreciation. The 5% baby bond FCRX trades at $24.54 with a yield to maturity of 7.16%, offering a 2% higher yield compared to sector benchmarks. CCAP's adjusted credit score equivalent for financial strength is Baa2. It has strong profitability, asset quality, and leverage, though it relies on refinancing unsecured notes.

AstraZeneca (AZN) Reels from China Investigation and Investor Suit - Hagens Berman — Neutral
AZN Accesswire — February 11, 2025AZN Investors with Losses Encouraged to Contact the Firm Before Feb. 21, 2025 Deadline SAN FRANCISCO, CA / ACCESS Newswire / February 11, 2025 / AstraZeneca (NASDAQ:AZN), the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15 percent over the past six months, buffeted by a series of unsettling reports emanating from China. A widening investigation by China regulators into alleged illegal drug imports, data breaches, and potential health insurance fraud has cast a shadow over the company's prospects in a critical market, triggering a securities class action lawsuit in the United States.

S&P Global Inc. (SPGI) Q4 2024 Earnings Call Transcript — Neutral
SPGI Seeking Alpha — February 11, 2025S&P Global Inc. (NYSE:SPGI ) Q4 2024 Earnings Conference Call February 11, 2025 8:30 AM ET Company Participants Mark Grant - SVP of IR Martina Cheung - President and CEO Chris Craig - Interim CFO Conference Call Participants Manav Patnaik - Barclays Alex Kramm - UBS Faiza Alwy - Deutsche Bank Ashish Sabadra - RBC Capital Markets Toni Kaplan - Morgan Stanley Jeff Silber - BMO Capital Markets George Tong - Goldman Sachs Andrew Steinerman - JPMorgan Andrew Nicholas - William Blair Peter Christiansen - Citi David Motemaden - Evercore Owen Lau - Oppenheimer Shlomo Rosenbaum - Stifel Jason Haas …

Royalty Pharma plc (RPRX) Q4 2024 Earnings Call Transcript — Neutral
RPRX Seeking Alpha — February 11, 2025Royalty Pharma plc (NASDAQ:RPRX ) Q4 2024 Earnings Conference Call February 11, 2024 8:30 AM ET Company Participants George Grofik - SVP, Head, Investor Relations and Communications Pablo Legorreta - Founder & CEO Marshall Urist - EVP, Head-Research and Investments Christopher Hite - Vice Chairman & Executive VP Terrance Coyne - Executive VP & CFO Conference Call Participants Geoffrey Meacham - Citi Christopher Schott - JPMorgan Chase & Co Michael Nedelcovych - TD Cowen Chris Shibutani - Goldman Sachs Dina Ramadane - Bank of America Securities. Ashwani Verma - UBS Operator Ladies and gentlemen, thank you for standing by, and …

Encompass Health Q4 Earnings Beat on Strong Discharge Growth — Positive
EHC Zacks Investment Research — February 11, 2025EHC expects adjusted EPS from continuing operations in the range of $4.67-$4.96 in 2025.

Jim Cramer Says These 2 Large Cap Dividend Stocks Are Hot February Buys — Positive
MRK WMT 24/7 Wall Street — February 11, 2025Media personality Jim Cramer often makes bold statements about companies and a lot of times, he proves himself correct.

Glo Fiber Brings Lightning Fast Fiber Optic Internet to Berryville, VA — Neutral
SHEN PRNewsWire — February 11, 2025Expansion will bring internet speeds up to 5 Gbps to the county seat of Clarke County EDINBURG, Va. , Feb. 11, 2025 /PRNewswire/ -- Glo Fiber, powered by Shenandoah Telecommunications Company ("Shentel") (Nasdaq: SHEN), announced they have reached an agreement to deploy next generation fiber-to-the-home (FTTH) broadband services to Berryville, Virginia.

AGNC's Q4 earnings were mixed – to say the least – upon first glance. However, I believe the headwinds to be only temporary and thus see more upside ahead. The TBV/share continued to decline in its Q4 earnings, which remains a concern in my mind.

Apollo Commercial Real Estate Finance, Inc. (ARI) Q4 2024 Earnings Call Transcript — Neutral
ARI Seeking Alpha — February 11, 2025Apollo Commercial Real Estate Finance, Inc. (NYSE:ARI ) Q4 2024 Results Conference Call February 11, 2025 10:00 AM ET Company Participants Stuart Rothstein - President and Chief Executive Officer Anastasia Mironova - Chief Financial Officer Scott Weiner - Chief Investment Officer Conference Call Participants Rick Shane - JPMorgan Jade Rahmani - KBW Steve Delaney - Citizens JMP Securities John Nickodemus - BTIG Harsh Hemnani - Green Street Operator I'd like to remind everyone that today's call and webcast are being recorded. Please note that they are the property of Apollo Commercial Real Estate Finance, Inc. and that any unauthorized broadcast …

Vornado's Q4 FFO & Revenues Beat Estimates, Same-Store NOI Declines — Positive
VNO Zacks Investment Research — February 11, 2025VNO's Q4 results reflect better-than-anticipated revenues on decent leasing activity. However, total same-store NOI declines across the portfolio.

Google Files Patent for AI Chatbot That Answers Phone Calls — Positive
GOOG GOOGL PYMNTS — February 11, 2025Google has filed a patent for a personalized artificial intelligence (AI)-powered chatbot that can answer — and respond to — phone calls on your behalf. The U.S. Patent and Trademark Office published the patent filing on Tuesday (Feb.

Nano Nuclear Energy is a vertically integrated nuclear energy firm, focusing on microreactors and high-assay low-enriched uranium production. NNE's microreactors are portable, easy-to-operate power stations, with their flagship product "Zeus" receiving support from the U.S. Department of Energy. Despite being pre-revenue and potentially unprofitable until 2034, NNE's vertical integration and government partnerships offer significant long-term growth potential.

Kinetic Business Deploys Calix SmartBiz To Power Productivity Gains for Businesses in 18 States — Neutral
CALX Business Wire — February 11, 2025SAN JOSE, Calif.--(BUSINESS WIRE)---- $CALX #calix--Calix, Inc. (NYSE: CALX) announces that Kinetic Business, a leading fiber internet provider, has launched Calix SmartBiz™ to boost productivity and operational efficiency for businesses in small towns and big cities. SmartBiz, integrated with the cloud-enabled Calix Broadband Platform, is a purpose-built solution that enables broadband service providers (BSPs) to quickly expand their small business markets. SmartBiz is easy to deploy, manage, and scale while k.

Block, Inc. (XYZ) Faces Securities Class Action, Regulators Levy Cash App Fines Following Investigations Going Back to Hindenburg Report– Hagens Berman — Neutral
SQ XYZ Accesswire — February 11, 2025XYZ Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESS Newswire / February 11, 2025 / Investors in Block, Inc. (NYSE:SQ) n/k/a (NYSE:XYZ) began to learn of potentially adverse information about the company and its Square and Cash App platforms on Mar. 23, 2023, when Hindenburg Research published a scathing report on the company. After a 2-year investigation, which included dozens of interviews with former employees, partners, and industry experts, Hindenburg concluded, in part, that Block had "wildly overstated its genuine user counts" and "[c]ore to the issue is that Block has embraced one traditionally ‘underbanked' …

Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design - Hagens Berman — Neutral
NVO Accesswire — February 11, 2025SAN FRANCISCO, CA / ACCESS Newswire / February 11, 2025 / Novo Nordisk A/S (NYSE:NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the prospects of its experimental obesity drug, CagriSema. Hagens Berman urges investors who purchased Novo Nordisk shares and suffered substantial losses to submit your losses now.
